NFKBIA and acute myeloid leukemia: In this study, our preliminary ex vivo results showed that the combination of GILT and NFKB-I could effectively reduce primary FLT3mut AML blasts by inhibiting their cell cycle initiation, cluster formation and release of pro-survival cytokines.